| [1] |
[J].Thorax,2001,56(2):89-108.
|
| [2] |
李金翰.非小细胞肺癌治疗的共识点、难点和亮点[J].中国肺癌杂志,2003,6(5):344-346.
|
| [3] |
Marom EM,Mcadams HP,Erasmus JJ,et al.Staging non-small cell lung cancer with whole-body PET[J].Radiology,1999,212(3): 803-809.
|
| [4] |
[ll] Weber WA,Petersen V,Schmidt B,et al.Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use[J].J Clin Oncol,2003,21(14):2651-2657.
|
| [5] |
Vansteenkiste JF,Stroobants SG,De Leyn PR,et al.Lymph node staging in non-small-cell lung cancer with FDG-PET scan:a prospective study on 690 lymph node stations from 68 patients[J].J Clin Oncol,1998,16(6):2142-2149.
|
| [6] |
赵春雷,高硕,陈秋松,等.18F-FDG PET/CT显像在非小细胞肺癌术前分期中的价值[J].中华核医学杂志,2005,25(2):78-81.
|
| [7] |
Mcloud TC,Bourgouin PM,Greenberg RW,et al.Bmnehogenic carcinoma:analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling[J].Radiology,1992, 182(2):319-323.
|
| [8] |
刘素文,于金明,邓力刚.18F-FDG PET显像在非小细胞肺癌临床分期中的价值[J].中华肿瘤杂志,2004,26(10):626-629.
|
| [9] |
British Thoracic Society,Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party.BTS guidelines: Guidelines on the selection of patients with lung cancer for surgery.
|
| [10] |
关志伟,姚树林,田嘉禾,等.PET诊断肺部肿瘤的SUV值与灵敏度分析[J].中国l临床医学影像杂志,2003,14(3):169-172.
|
| [11] |
孔令山,刘靖,秦杰,等.标准摄取值在诊断肺占位性病变中的价值及其影响因素fJ.中国医学影像技术,2005,21(1):18-20.
|
| [12] |
Zimany M,Kaiser HJ,Wildberger J,et al.Analysis of FDG uptake with hybrid PET using standardized uptake values[J].Eur J Nucl Med.2001,28(5):586-592.
|
| [13] |
Yamamoto Y,Nishiyama Y,Monden T,et al.Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung eancer[J].Eur J Nucl Med Mol Imaging,2006,33(2):140-147.
|
| [14] |
Ryu JS,Choi NC,Fischman AJ,et al.FDG-PET in staging and resraging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology[J].Lung Cancer,2002,35(2):179-187.
|